Which of the following anti-diabetic drugs causes weight loss?
সমাধান
সঠিক উত্তর: Option A
English Explanation
Liraglutide is a GLP-1 receptor agonist that effectively causes weight loss. It works by delaying gastric emptying and acting on the hypothalamus to increase satiety (feeling of fullness), thereby reducing overall food intake.
Among the other options, Glimepiride (a Sulfonylurea), Pioglitazone (a Thiazolidinedione), and Insulin are well-known to cause weight gain. Insulin and Sulfonylureas cause weight gain due to their anabolic effects and increased risk of hypoglycemia (which prompts eating), while Pioglitazone causes weight gain through fluid retention and increased adipogenesis.
বাংলা ব্যাখ্যা
Liraglutide হলো একটি GLP-1 receptor agonist যা কার্যকরভাবে weight loss বা ওজন হ্রাস করে। এটি পাকস্থলীর gastric emptying বিলম্বিত করে এবং মস্তিষ্কে satiety (তৃপ্তি) বৃদ্ধি করে, যার ফলে রোগীর খাবার গ্রহণের পরিমাণ কমে যায়।
অন্যান্য অপশনগুলোর মধ্যে Glimepiride (Sulfonylurea), Pioglitazone (Thiazolidinedione) এবং Insulin সাধারণত weight gain বা ওজন বৃদ্ধি করে। এদের অ্যানাবলিক প্রভাব, ফ্লুইড রিটেনশন বা এডিপোজেনেসিস বৃদ্ধির কারণে রোগীর ওজন বাড়ে।
BCS High Yield Points
- Anti-diabetic drugs causing weight loss: GLP-1 agonists (Liraglutide, Exenatide, Semaglutide) and SGLT2 inhibitors (Empagliflozin, Dapagliflozin).
- Anti-diabetic drugs causing weight gain: Sulfonylureas, Thiazolidinediones (Pioglitazone), Meglitinides, and Insulin.
- Anti-diabetic drugs that are weight neutral: Metformin (can cause mild weight loss) and DPP-4 inhibitors (Sitagliptin, Vildagliptin).
- Liraglutide is administered via subcutaneous injection and is also FDA-approved specifically for obesity management.
- GLP-1 agonists and SGLT2 inhibitors are highly preferred in diabetic patients with established cardiovascular diseases due to their cardioprotective benefits.
Source: Katzung's Basic and Clinical Pharmacology, Lippincott Illustrated Reviews
Liraglutide is a GLP-1 receptor agonist that effectively causes weight loss. It works by delaying gastric emptying and acting on the hypothalamus to increase satiety (feeling of fullness), thereby reducing overall food intake.
Among the other options, Glimepiride (a Sulfonylurea), Pioglitazone (a Thiazolidinedione), and Insulin are well-known to cause weight gain. Insulin and Sulfonylureas cause weight gain due to their anabolic effects and increased risk of hypoglycemia (which prompts eating), while Pioglitazone causes weight gain through fluid retention and increased adipogenesis.
বাংলা ব্যাখ্যা
Liraglutide হলো একটি GLP-1 receptor agonist যা কার্যকরভাবে weight loss বা ওজন হ্রাস করে। এটি পাকস্থলীর gastric emptying বিলম্বিত করে এবং মস্তিষ্কে satiety (তৃপ্তি) বৃদ্ধি করে, যার ফলে রোগীর খাবার গ্রহণের পরিমাণ কমে যায়।
অন্যান্য অপশনগুলোর মধ্যে Glimepiride (Sulfonylurea), Pioglitazone (Thiazolidinedione) এবং Insulin সাধারণত weight gain বা ওজন বৃদ্ধি করে। এদের অ্যানাবলিক প্রভাব, ফ্লুইড রিটেনশন বা এডিপোজেনেসিস বৃদ্ধির কারণে রোগীর ওজন বাড়ে।
BCS High Yield Points
- Anti-diabetic drugs causing weight loss: GLP-1 agonists (Liraglutide, Exenatide, Semaglutide) and SGLT2 inhibitors (Empagliflozin, Dapagliflozin).
- Anti-diabetic drugs causing weight gain: Sulfonylureas, Thiazolidinediones (Pioglitazone), Meglitinides, and Insulin.
- Anti-diabetic drugs that are weight neutral: Metformin (can cause mild weight loss) and DPP-4 inhibitors (Sitagliptin, Vildagliptin).
- Liraglutide is administered via subcutaneous injection and is also FDA-approved specifically for obesity management.
- GLP-1 agonists and SGLT2 inhibitors are highly preferred in diabetic patients with established cardiovascular diseases due to their cardioprotective benefits.
Source: Katzung's Basic and Clinical Pharmacology, Lippincott Illustrated Reviews